批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/07/10 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/09/27 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/12/17 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/12/17 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/02/18 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/02/18 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/02/27 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/05 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/24 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
UNKNOWN
|
|
|
2013/09/16 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CAPECITABINE 剂型/给药途径:TABLET;ORAL 规格:150MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020896 |
001 |
NDA |
XELODA |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
Yes |
No |
AB |
1998/04/30
|
CHEPLAPHARM |
091649 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2013/09/16
|
TEVA PHARMS USA |
090943 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2014/08/08
|
RISING |
202593 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2015/04/23
|
ACCORD HLTHCARE |
200483 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Discontinued |
No |
No |
AB |
2016/07/14
|
HIKMA |
207456 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2016/12/12
|
SHILPA |
204741 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Discontinued |
No |
No |
AB |
2017/02/28
|
AMNEAL PHARMS |
207652 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2017/11/24
|
ALKEM LABS LTD |
210604 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2018/04/17
|
EUGIA PHARMA |
209365 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2018/07/02
|
MSN |
204668 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Discontinued |
No |
No |
AB |
2019/06/21
|
SUN PHARM |
211724 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2020/04/27
|
RELIANCE LIFE |
204345 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2020/12/04
|
DR REDDYS |
217237 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2023/10/23
|
TEYRO LABS |
210203 |
001 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2024/03/05
|
HETERO LABS LTD V |
活性成分:CAPECITABINE 剂型/给药途径:TABLET;ORAL 规格:500MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020896 |
002 |
NDA |
XELODA |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
Yes |
Yes |
AB |
1998/04/30
|
CHEPLAPHARM |
091649 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2013/09/16
|
TEVA PHARMS USA |
090943 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2014/08/08
|
RISING |
202593 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2015/04/23
|
ACCORD HLTHCARE |
200483 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Discontinued |
No |
No |
AB |
2016/07/14
|
HIKMA |
207456 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2016/12/12
|
SHILPA |
204741 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Discontinued |
No |
No |
AB |
2017/02/28
|
AMNEAL PHARMS |
207652 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2017/11/24
|
ALKEM LABS LTD |
210604 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2018/04/17
|
EUGIA PHARMA |
209365 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2018/07/02
|
MSN |
204668 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Discontinued |
No |
No |
AB |
2019/06/21
|
SUN PHARM |
211724 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2020/04/27
|
RELIANCE LIFE |
204345 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2020/12/04
|
DR REDDYS |
217237 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2023/10/23
|
TEYRO LABS |
210203 |
002 |
ANDA |
CAPECITABINE |
CAPECITABINE |
TABLET;ORAL |
500MG |
Prescription |
No |
No |
AB |
2024/03/05
|
HETERO LABS LTD V |